Medical Center Comac Medical Ltd. — Clinical Trial Site

31 Registered trials

8 Currently recruiting

Organisation

Medical Center Comac Medical Ltd.

Location

Sofia, Bulgaria

Identifier

ORG-100045966

Address

Ulitsa Urvich 13, Krasno Selo District, 1612, Bulgaria

Departments

#1004
0901:NA
Clinical Research unit
Clinical Research Unit for Phase I
COMAC Medical
Comac medical department
MC Comac medical
Medical Center Comac Medical Ltd
N/A
NA
NAP
Not Applicable
Skin and Venereal Diseases

Clinical trials at this site (31)

Search interface

A study to compare the relative potency of salbutamol administered via metered dose inhalers containing propellants HFA-152a to HFA-134a in … Pending

2024-511220-14-00 Mild Asthma 3
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed by the Body in Men With Prostate Ca… Pending

2024-520286-31-00 Hot Flush 3
(22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coro… Pending

2025-522335-34-00 Chronic kidney disease 3
A multi-part, adaptive, Phase 1, first time in human study in healthy participants and participants with atopic dermatitis (AD) to assess th… Recruiting

2025-522216-17-00 Atopic Dermatitis 1 2026-01-26
Evaluation of safety, side effects and how the drug CHF6467 administrated via intranasal route is absorbed, modified and removed in healthy … Recruiting

2025-521455-23-00 Neonatal Hypoxic-Ischemic Encephalopathy (HIE) 3 2025-09-11
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis Recruiting

2025-520705-12-00 Colitis Ulcerative 4 2025-06-24
A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-t… Recruiting

2024-512496-12-00 Moderate to Severe Plaque Psoriasis 5 2025-04-01
Long-term safety and efficacy evaluation of lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP) who comp… Ended

2024-515912-27-00 Chronic rhinosinusitis with nasal polyps 4 2025-12-08
A phase Ib, open-label, ascending dose study with step-up doses to assess safety, tolerability, and pharmacokinetics of PIT565 in participan… Ended

2023-510025-14-00 Systemic Lupus Erythematosus 3 2024-10-08
A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Fu… Ended

2025-521502-18-00 Tuberculosis 3 2025-11-13
Cardiovascular safety assessment of Tanimilast in healthy volunteers Ended

2024-516861-35-00 This is Phase I study to assess the effect on the heart 3 2025-07-31
A multicentric, open-label, non-randomized study to evaluate the pharmacokinetic, safety and tolerability of ITF2357 given as an oral single… Ended

2024-513577-43-00 Participants with normal hepatic function 3 2025-05-16
A comparison study between adolescents with asthma and adults with asthma on how they absorb, metabolise and eliminate CHF 6001 Ended

2024-516483-29-00 Asthma 4 2025-03-24
Open-label, non-randomised, single-dose, one sequence, two-period, cross-over study to investigate the effect of inhibition of P-glycoprotei… Ended

2024-516475-32-00 Chronic obstructive pulmonary disease 3 2025-03-17
A proof-of-concept study of lunsekimig compared with placebo in adults with chronic rhinosinusitis with nasal polyps Ended

2024-511261-11-00 Respiratory tract diseases 4 2025-03-05
An open-label, DDI study to investigate the effects of amlitelimab on the PK of selected cytochrome P450 substrates Ended

2024-513495-17-00 Dermatitis atopic 3 2024-11-20
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment Ended

2024-514359-14-00 Impaired renal function 3 2024-11-18
A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Parti… Ended

2024-513848-28-00 Healthy Volunteers 3 2024-11-11
Phase Ib Randomised, Placebo-controlled, Double-blind, Multicentre Study to Assess the Effects and Safety of AZD5462 on top of Dapagliflozin… Ended

2024-513142-11-00 Moderate Renal Impairment 3 2024-09-27
A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in adult participants with severe … Ended

2024-511225-64-00 Alopecia areata 4 2024-09-18
An open label, randomized, single-dose, two-sequence, two-period, crossover comparative bioavailability study to assess the pharmacokinetic … Ended

2023-510176-31-00 This study is a phase I trial, a single-dose, open labe 3 2024-07-22
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 With a Randomized Withdrawal and Retreatment Period in Subject… Ended

2023-505842-24-00 Moderate to Severe Plaque Psoriasis 5 2024-05-07
Effects of Nicotine 1.5mg lozenge on smoking urges in moderate smokers Ended

2023-506787-13-00 Cessation of smoking 5 2024-04-03
Effect of Erythromycin on the absorption, metabolism and elimination of CHF6001 in healthy volunteers Ended

2023-507300-30-00 This study is a phase I trial to investigate the effec 3 2024-03-27